For now, retatrutide remains in clinical trials with uncertain approval timeline
BPC-157 (Body Protection Compound 157) ist ein synthetisches Pentadecapeptid aus 15 Aminosuren, das von einer partiellen Sequenz eines im menschlichen Magensaft vorkommenden Schutzproteins abgeleitet wurde
Role of topical ketoconazole in therapeutic hair care
Coverage at NY Times, front page today and my input to that piece To view or add a comment, sign in This week, an FDA advisory committee voted to allow BPC-157 and several other peptides to be used in pharmacy compounding
Symptoms include fatigue, weakness, pale skin, shortness of breath, constipation, and tingling in the hands and feet
This systemic reach makes the BPC-157 TB-500 blend particularly relevant for research involving diffuse or multi-site tissue damage